Target intelligence / Profile preview

Diagnosis of hematological diseases

01

Overview

Diagnosis of hematological diseases is a clinical and laboratory process used to identify and characterize disorders of the blood, bone marrow, and lymphatic system. It is not a single molecular target, receptor, or enzyme, but rather a multidisciplinary medical field encompassing the evaluation of conditions like leukemia, lymphoma, and various anemias. The diagnostic workflow typically involves integrating clinical history with physical examination and a battery of tests, including complete blood counts, microscopic morphologic assessment, flow cytometry for immunophenotyping, and advanced genetic sequencing to identify driver mutations. While this process is fundamental for identifying specific therapeutic targets (such as CD19 in B-cell malignancies or JAK2 in myeloproliferative neoplasms), the diagnostic process itself cannot be targeted by pharmacological agents. Analysts should recognize this as a clinical indication or diagnostic category rather than a druggable biological entity.

Other names
Hematologic diagnosisHematological diagnostic testingEvaluation of blood disordersHematopathology
02

Mechanism of action

Not applicable. This is a clinical process and diagnostic category rather than a molecular target.

03

Disease associations

LeukemiaLymphomaMultiple myelomaMyelodysplastic syndromesAnemiaHemophiliaThrombocytopenia
04

Safety considerations

Invasive procedural risks (e.g., hemorrhage or infection from bone marrow biopsy)Diagnostic errors or misinterpretation of complex pathologySample degradation affecting laboratory accuracy
05

Biomarkers

Complete blood count (CBC)Peripheral blood smearBone marrow aspiration and biopsyFlow cytometry (e.g., CD markers)Cytogenetic analysis (e.g., Karyotyping, FISH)Molecular testing (e.g., PCR for BCR-ABL1, NGS for FLT3/NPM1)

Beyond the preview

Go deeper on Diagnosis of hematological diseases.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagnosis of hematological diseases.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call